Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Preface promotion: free to download

Volume:4   Issue:3
Pp: i-i
Martin Tenniswood
DOI: 10.2174/1389450033491172

Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

Volume:4   Issue:3
Pp: 191-196
Aristotelis G. Anastasiadis, Debra L. Bemis, Brian C. Stisser, Laurent Salomon, Mohamed A. Ghafar and Ralph Buttyan
DOI: 10.2174/1389450033491136

TGF-ß / Smad Signaling in Prostate Cancer

Volume:4   Issue:3
Pp: 197-207
Diana Bello-DeOcampo and Donald J. Tindall
DOI: 10.2174/1389450033491118

Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer

Volume:4   Issue:3
Pp: 209-221
Martin Gleave, Colleen Nelson and Kim Chi
DOI: 10.2174/1389450033491190

Par-4 for Molecular Therapy of Prostate Cancer

Volume:4   Issue:3
Pp: 223-230
James Butler and Vivek M. Rangnekar
DOI: 10.2174/1389450033491163

Phytoestrogens and Prostate Cancer

Volume:4   Issue:3
Pp: 231-241
Colm Morrissey and R. William G. Watson
DOI: 10.2174/1389450033491154

From TGF-β to Cancer Therapy

Volume:4   Issue:3
Pp: 243-250
Xuemei Huang and Chung Lee
DOI: 10.2174/1389450033491181

Therapeutic Targets for Metastatic Prostate Cancer

Volume:4   Issue:3
Pp: 251-261
Terry L. Timme, Takefumi Satoh, Salahaldin A. Tahir, Hongyu Wang, Bin S. The, E. Brian Butler, Brian J. Miles, Robert J. Amato, Dov Kadmon and Timothy C. Thompson
DOI: 10.2174/1389450033491127

Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate Cancer

Volume:4   Issue:3
Pp: 263-279
W. C. Powell, R. D. Cardiff, M. B. Cohen, G. J. Miller and P. Roy-Burman
DOI: 10.2174/1389450033491145